Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK)Charles L Cywin, Bao-Ping Zhao, Daniel W McNeil, et al.Journal of Medicinal Chemistry|April 9, 2015
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep)William H Parsons, Raul R Calvo, Wing Cheung, et al.Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.Journal of Medicinal Chemistry|November 2, 2011
Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141)Carl R Illig, Carl L Manthey, Mark J Wall, et al.Bioorganic & Medicinal Chemistry Letters|October 22, 2013
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitorsCarl R Illig, Carl L Manthey, Sanath K Meegalla, et al.Bioorganic & Medicinal Chemistry Letters|April 19, 2008
Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motifKevin D Kreutter, Tianbao Lu, Lily Lee, et al.Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Synthesis and evaluation of novel 3,4,6-substituted 2-quinolones as FMS kinase inhibitorsMark J Wall, Jinsheng Chen, Sanath Meegalla, et al.The Journal of Pharmacology and Experimental Therapeutics|June 7, 2024
Pan AMPK Activation Protects Tubules in Rat Ischemic Acute Kidney InjuryHenriette Frikke-Schmidt, Kamal Albarazanji, Jenson Qi, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
Pan AMPK activation protects tubules in rat ischemic acute kidney injuryHenriette Frikke-Schmidt, Kamal Albarazanji, Jenson Qi, et al.Pageof 5